These effects, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 aid the thought of focusing on ACKR3 as a novel method to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked Diseases. Conolidine statements being a https://billv061uka7.wikinewspaper.com/user